Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
Tau PET performs well in predicting dementia in individuals with MCI
Jun 12, 2024
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
Self-, partner-reported cognitive decline linked to tau
May 30, 2024
Significant associations were seen between self- and study partner-reported Cognitive Function Index and tau driven by elevated Aβ.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Benefit of thick liquids in Alzheimer’s disease and dysphagia unclear
May 06, 2024
Patients receiving thick versus thin liquids were less likely to be intubated and more likely to have respiratory complications.
Differences ID’d in tau burden in Down syndrome, Alzheimer’s disease
Apr 25, 2024
Differences in spatial distribution, timing and magnitude of tau burden were seen for two genetic forms of Alzheimer’s disease.